Episode
First Clinical Trial for Broken Heart Syndrome
- Published
- May 18, 2026
- Duration seconds
- 112
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/glasgow-news-today-2-min-news-the-daily-news-now-7610185/episodes/first-clinical-trial-for-broken-heart-syndrome/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/glasgow-news-today-2-min-news-the-daily-news-now-7610185/first-clinical-trial-for-broken-heart-syndrome.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Breaking News: First-Ever Clinical Trial for Broken Heart Syndrome Launched A groundbreaking seven-year study is underway to find a treatment for takotsubo cardiomyopathy, a condition triggered by intense emotional stress that affects thousands of people, mostly women, each year. The trial, involving nearly a thousand patients across forty hospitals, is testing renin-angiotensin system inhibitors (RAS inhibitors) to prevent future heart attacks, strokes, heart failure, and more takotsubo episodes. This could be the first real therapy specifically for this condition, potentially improving the lives of those affected worldwide. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/c8717ef936a7d9d3